Your browser doesn't support javascript.
loading
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
Moore, Kathleen N; Bookman, Michael; Sehouli, Jalid; Miller, Austin; Anderson, Charles; Scambia, Giovanni; Myers, Tashanna; Taskiran, Cagatay; Robison, Katina; Mäenpää, Johanna; Willmott, Lyndsay; Colombo, Nicoletta; Thomes-Pepin, Jessica; Liontos, Michalis; Gold, Michael A; Garcia, Yolanda; Sharma, Sudarshan K; Darus, Christopher J; Aghajanian, Carol; Okamoto, Aikou; Wu, Xiaohua; Safin, Rustem; Wu, Fan; Molinero, Luciana; Maiya, Vidya; Khor, Victor K; Lin, Yvonne G; Pignata, Sandro.
Afiliação
  • Moore KN; Gynecologic Oncology Group Foundation (GOG-F) and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Bookman M; Sarah Cannon Research Institute, Nashville, TN.
  • Sehouli J; GOG-F and Kaiser Permanente Northern California, San Francisco, CA.
  • Miller A; Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (North-Eastern German Society of Gynaecologic Oncology; NOGGO), Berlin, Germany and Charité-Medical University of Berlin (Campus Virchow Klinikum), Berlin, Germany.
  • Anderson C; GOG-F and Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Scambia G; GOG-F and Willamette Valley Cancer Institute, Eugene, OR.
  • Myers T; Mario Negri Gynecologic Oncology (MaNGO) and Fondazione Policlinico Universitario Gemelli Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Taskiran C; GOG-F and Baystate Medical Center, Springfield, MA.
  • Robison K; Turkish Society of Gynecologic Oncology (TRSGO) and Koç University School of Medicine, Istanbul, Turkey.
  • Mäenpää J; Vehbi Koç Vakfi American Hospital, Istanbul, Turkey.
  • Willmott L; GOG-F and Women and Infants Hospital, Providence, RI.
  • Colombo N; Nordic Society of Gynaecological Oncology (NSGO) and Tampere University and University Hospital, Tampere, Finland.
  • Thomes-Pepin J; GOG-F and Arizona Oncology Associates, PC, Phoenix, AZ.
  • Liontos M; European Institute of Oncology, IRCCS, and University of Milan-Bicocca, Milan, Italy.
  • Gold MA; GOG-F and Minnesota Oncology, Maplewood, MN.
  • Garcia Y; Hellenic Cooperative Oncology Group (HeCOG) and National & Kapodistrian University of Athens, Athens, Greece.
  • Sharma SK; GOG-F and Oklahoma Cancer Specialists, Tulsa, OK.
  • Darus CJ; Grupo Español de Investigación en Cáncer de Ovario (GEICO) and Parc Taulí University Hospital, Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Aghajanian C; GOG-F and Department of Obstetrics/Gynecology, Amita Adventist Hinsdale Hospital, Hinsdale, IL.
  • Okamoto A; GOG-F and Maine Medical Center, Scarborough, ME; Current Affiliation: Earle A. Chiles Research Institute at Providence Cancer Institute, Portland, OR.
  • Wu X; GOG-F and Memorial Sloan Kettering Cancer Center, New York, NY.
  • Safin R; The Jikei University School of Medicine, Tokyo, Japan.
  • Wu F; Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Molinero L; Republican Clinical Oncology Dispensary of the Ministry of Health of Republic of Tatarstan, Kazan, Russian Federation.
  • Maiya V; Biostatistics, Roche (China) Holding Ltd, Shanghai, China.
  • Khor VK; Genentech Inc, South San Francisco, CA.
  • Lin YG; Genentech Inc, South San Francisco, CA.
  • Pignata S; Genentech Inc, South San Francisco, CA.
J Clin Oncol ; 39(17): 1842-1855, 2021 06 10.
Article em En | MEDLINE | ID: mdl-33891472
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Epitelial do Ovário Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Epitelial do Ovário Idioma: En Ano de publicação: 2021 Tipo de documento: Article